Compare ONC & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONC | FE |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 29.0B |
| IPO Year | N/A | 2005 |
| Metric | ONC | FE |
|---|---|---|
| Price | $317.89 | $51.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $377.33 | $48.86 |
| AVG Volume (30 Days) | 234.7K | ★ 4.9M |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | N/A | ★ 3.48% |
| EPS Growth | N/A | ★ 3.53 |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $15,090,000,000.00 |
| Revenue This Year | $770.07 | $1.72 |
| Revenue Next Year | $15.48 | $4.08 |
| P/E Ratio | $614.06 | ★ $29.10 |
| Revenue Growth | N/A | ★ 12.01 |
| 52 Week Low | $196.53 | $37.58 |
| 52 Week High | $385.22 | $51.34 |
| Indicator | ONC | FE |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 75.48 |
| Support Level | $307.93 | $45.77 |
| Resistance Level | $350.56 | N/A |
| Average True Range (ATR) | 10.46 | 0.93 |
| MACD | -4.21 | 0.19 |
| Stochastic Oscillator | 6.49 | 97.90 |
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
FirstEnergy is an investor-owned holding company with operations across five mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.